- PR Newswire•11 hours agoNVO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Novo Nordisk A/S and a Lead Plaintiff Deadline of March 13, 2017
NEW YORK, Feb. 22, 2017 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased ...
- PR Newswire•13 hours ago
MISSISSAUGA, ON, Feb. 22, 2017 /CNW/ - The Canadian Obesity Network, in partnership with Novo Nordisk Canada Inc., is calling on Canadian media to re-examine how people living with obesity are portrayed in news stories and to use non-biased, respectful images. Often, the media use images to accompany news stories that depict people living with obesity from unflattering angles, focusing on the abdomen or lower body with the head cut out of the frame, and frequently consuming unhealthy food or engaged in sedentary activity.1 Widespread use of these stereotypical "fat-shaming" images can promote weight bias and discrimination, a significant cause of distress in people living with obesity. "We want to work with the media to encourage a shift from the use of imagery that depicts people living with obesity in a negative light, to one that looks at the whole picture," said Dr. Arya Sharma, Founder and Scientific Director of the Canadian Obesity Network.
- Market Realist•3 days ago
Sanofi has reorganized its diabetes and cardiovascular franchise, making it one of the largest revenue contributors to the pharmaceutical business.
NVO : Summary for Novo Nordisk A/S Common Stock - Yahoo Finance
Novo Nordisk A/S (NVO)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||35.13 - 35.40|
|52 Week Range||30.89 - 57.81|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.31|
|Dividend & Yield||1.12 (3.15%)|
|1y Target Est||N/A|